Immunophotonics’ Tomas Hode, PhD (CIO and President) is attending Spectrum Conference, January 16 – 18, in Miami, Florida.

Some of the leading experts in the field of interventional oncology will be sharing their insights on the latest advancements in the fight against cancer at this esteemed even. Tomas is excited to connect with such talented individuals and to learn about the latest developments in interventional therapeutics to advance clinical trials of IP-001 forward with the ultimate goal of making this drug candidate available to patients in need as quickly as possible.